Bimatrix

Bimatrix sells ophthalmic surgical equipment, specializing in phaco-emulsification and vitrectomy systems, disposable hand-pieces, and intraocular lenses. Price points sit in the mid-to-premium tier; capital consoles list at roughly US $60-90k and single-use packs at US $120-180. The company sells direct to hospitals and ambulatory surgery centers worldwide, supported by a small network of country distributors and an online customer portal for re-orders and service tickets. The brand’s signature is a modular phaco platform that lets surgeons hot-swap ultrasound, vitrectomy, and IOP-control modules on one cart, cutting capital cost per function by about 30%. Its 2018 launch of the “UltraSil” hydrophobic acrylic IOL with a 360° square edge is now implanted in >1.2 million eyes and is cited for a published 2.1% posterior-capsule opacification rate at three years. All consoles ship with an open-architecture software interface that accepts third-party tubing sets, a rarity in a field dominated by closed ecosystems. Target buyers are high-volume cataract and retinal surgeons in both public hospitals and private clinics that need Swiss-level reliability on a Mediterranean budget. Customers value the mix of European engineering (CE 2460 certification, ISO 13485) and lower per-procedure cost, aligning with value-based procurement mandates now common in EU and LATAM health systems. Bimatrix competes against legacy premium phaco manufacturers whose closed consumables lock users into high per-case pricing. It differentiates through modular hardware, open consumables, and a five-year warranty that includes remote firmware updates—reducing total cost of ownership while still claiming surgical metrics (rise time, follow-ability, cut rates) within 5% of the category leaders.